Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Psychopharmacology

• Publication date

  2007-07-19

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-007-0880-2PMID 17639351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats.

  2006influential reference
• Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.

  2006influential reference
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.

  2006influential reference
• SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.

  2006cited by this paper
• Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation.

  2006influential reference
• The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.

  2006influential reference
• Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

  2006influential reference
• AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion

  2006influential reference
• Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

  2006cited by this paper
• The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis.

  2006cited by this paper
• Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.

  2005cited by this paper
• Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

  2005cited by this paper
• Rimonabant: the first therapeutically relevant cannabinoid antagonist.

  2005cited by this paper
• Prevalence of obesity in Great Britain

  2005cited by this paper
• Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.

  2005cited by this paper
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

  2005cited by this paper
• Endocannabinoid control of food intake and energy balance

  2005cited by this paper
• CB1 cannabinoid receptor‐mediated modulation of food intake in mice

  2005influential reference
• Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

  2005cited by this paper
• Endocannabinoids in the regulation of appetite and body weight

  2005influential reference
• Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

  2005cited by this paper
• Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.

  2005cited by this paper
• Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat.

  2004influential reference
• Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.

  2004influential reference
• Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.

  2004cited by this paper
• Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats.

  2004influential reference
• The gastrointestinal pharmacology of cannabinoids: an update.

  2004cited by this paper
• (−)-Adamantyl-Δ8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats

  2004influential reference
• The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents

  2003cited by this paper
• The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

  2003influential reference
• The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats.

  2003influential reference
• Cannabinoid agonists attenuate capsaicin‐induced responses in human skin

  2003cited by this paper
• The ATP-binding site of type II topoisomerases as a target for antibacterial drugs.

  2003cited by this paper
• Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats

  2003influential reference
• Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.

  2003influential reference
• Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after Δ9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716

  2003influential reference
• Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice

  2003influential reference
• The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

  2003influential reference
• The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

  2003cited by this paper
• Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats.

  2003cited by this paper
• Endogenous cannabinoid system as a modulator of food intake

  2003influential reference
• Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats.

  2003cited by this paper
• Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol

  2002cited by this paper
• Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

  2002cited by this paper
• Anti-obesity drug development

  2002influential reference
• Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine.

  2002cited by this paper
• Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

  2002influential reference
• Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.

  2002influential reference
• Prolonged effect of an anesthetic dose of ketamine on behavioral despair.

  2002cited by this paper
• Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.

  2002influential reference
• Observational analysis of feeding induced by Delta9-THC and anandamide.

  2002influential reference
• Orexins and appetite regulation.

  2002cited by this paper
• A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding

  2002influential reference
• SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats

  2001cited by this paper
• The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

  2001cited by this paper
• Drug treatment of obesity: from past failures to future successes?

  2001cited by this paper
• Anti-obesity drugs: a critical review of current therapies and future opportunities.

  2001influential reference
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• Pharmacotherapy of obesity: targets and perspectives.

  2001cited by this paper
• Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

  2001cited by this paper
• Δ9-Tetrahydrocannabinol Stimulates Palatable Food Intake in Lewis Rats: Effects of Peripheral and Central Administration

  2001cited by this paper
• Endogenous cannabinoids and appetite

  2001influential reference
• Obesity: are we any closer to identifying causes and effective treatments?

  2000cited by this paper
• Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

  2000influential reference
• Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

  2000cited by this paper
• Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.

  2000influential reference
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Patent focus on new anti-obesity agents: September 1999 - February 2000

  2000cited by this paper
• Obesity : Preventing and managing the global epidemic

  2000cited by this paper
• Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement

  2000cited by this paper
• Behavioral Effects of Cannabinoid Agents in Animals.

  1999cited by this paper
• Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

  1999influential reference
• Behavioral effects of cannabinoid agents in animals.

  1999cited by this paper
• Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.

  1998influential reference
• Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.

  1998influential reference
• Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

  1998cited by this paper
• Hyperphagia in pre-fed rats following oral delta9-THC.

  1998cited by this paper
• Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

  1998influential reference
• Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.

  1998cited by this paper
• CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.

  1998cited by this paper
• CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to Δ9-Tetrahydrocannabinol

  1998cited by this paper
• Hyperphagia in pre-fed rats following oral δ9-THC

  1998cited by this paper
• Role of the endogenous cannabinoid system in the regulation of motor activity.

  1998cited by this paper
• Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat

  1997influential reference
• Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.

  1997influential reference
• Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

  1997influential reference
• Cannabis: pharmacology and toxicology in animals and humans.

  1996cited by this paper
• Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.

  1996cited by this paper
• Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.

  1995cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994influential reference
• Molecular characterization of a peripheral receptor for cannabinoids

  1993influential reference
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol.

  1977cited by this paper
• Effects of marihuana use on body weight and caloric intake in humans

  1976cited by this paper
• Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine

  1971cited by this paper

• Pyrazole and Its Derivatives: An Excellent N-Hetrocycle with Wide Range of Biological Applications (A Review)

  2022cites this paper
• Interactions Between Alcohol and the Endocannabinoid System.

  2020cites this paper
• Behavioral assessment of rimonabant under acute and chronic conditions.

  2020cites this paper
• Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands

  2019cites this paper
• Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats

  2018cites this paper
• The Neurochemistry of Social Play Behaviour in Rats

  2018cites this paper
• Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor

  2017cites this paper
• Bench to bedside in appetite research: Lost in translation?

  2017cites this paper
• EFFECTOF CANNABINOID RECEPTORS 1 MODULATION ON OSTEOPOROSIS IN A RAT MODEL OF DIFFERENTAGES

  2017cites this paper
• Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats

  2016cites this paper
• Neurobiological Interactions Between Stress and the Endocannabinoid System

  2016cites this paper
• Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats.

  2016cites this paper
• Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice.

  2016cites this paper
• Impact of phenolic compounds on ACE and CCK signaling to reduce blood pressure and food intake

  2016cites this paper
• Mammalian Fatty Acid Amides of the Brain and CNS

  2014cites this paper
• The cannabinoid receptor 1 and its role in influencing peripheral metabolism

  2014cites this paper
• Physical activity and the endocannabinoid system: an overview

  2014cites this paper
• Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite

  2014cites this paper
• Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages.

  2014cites this paper
• Models and Strategies in the Development of Antiobesity Drugs

  2014cites this paper
• Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats

  2014cites this paper
• Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages

  2014cites this paper
• CB1 receptor signaling regulates social anxiety and memory

  2013cites this paper
• Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice

  2013cites this paper
• Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash

  2013cites this paper
• Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats

  2013cites this paper
• TRP Channels in Drug Discovery

  2012cites this paper
• Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity

  2012cites this paper
• Rodent Models to Evaluate Anti-obesity Drugs

  2012cites this paper
• BEHAVIORAL PHARMACOLOGY OF CANNABINOIDS: TOWARDS AN ANIMAL MODEL FOR STUDYING CANNABINOID DEPENDENCE/WITHDRAWAL

  2012cites this paper
• The utility of animal models to evaluate novel anti‐obesity agents

  2011cites this paper
• CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action

  2011cites this paper
• Cannabinoid Cb 1 Receptor Antagonists/Inverse Agonists and Food-Seeking Behavior

  2011cites this paper
• Effects of 2-AG on the reinforcing properties of wheel activity in obese and lean Zucker rats

  2010cites this paper
• Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?

  2010cites this paper
• The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.

  2010cites this paper
• Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

  2010cites this paper
• Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.

  2010cites this paper
• The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice

  2010influential citation
• Endocannabinoids in the aetiopathology of obesity – Central mechanisms

  2010cites this paper
• Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.

  2010cites this paper
• Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.

  2009cites this paper
• Night and day: diurnal differences in the behavioural satiety sequence in male rats.

  2009cites this paper
• Endocannabinoids and the non-homeostatic control of appetite.

  2009cites this paper
• Cannabinoids and appetite: Food craving and food pleasure

  2009cites this paper
• Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats

  2009cites this paper
• Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.

  2009influential citation
• Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats

  2009influential citation
• Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.

  2008cites this paper
• CLINICAL ASPECTS OF OBESITY AND CARDIOMETABOLIC DISEASE Background – Do We Need Drugs for Obesity ?

  2008cites this paper
• Taranabant cuts the fat: new hope for cannabinoid-based obesity therapies?

  2008cites this paper
• Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.

  2008cites this paper
• The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.

  2008influential citation
• Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

  2008influential citation
• Anti-obesity Drugs: From Animal Models to Clinical Efficacy

  2008cites this paper
• Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior

  2008cites this paper
• Anti-obesity drugs and neural circuits of feeding.

  2008cites this paper
• Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation

  2007cites this paper